Loading clinical trials...
Loading clinical trials...
Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants
Conditions
Interventions
INCB057643
Locations
1
United States
Celerion, Inc
Tempe, Arizona, United States
Start Date
May 12, 2025
Primary Completion Date
June 3, 2025
Completion Date
June 3, 2025
Last Updated
June 11, 2025
NCT07310264
NCT06342713
NCT07472361
NCT06649110
NCT06823947
NCT07240675
Lead Sponsor
Incyte Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions